Jing Cai

Prof. Jing Cai


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2017 in Oncotarget
Verified
Journal Article
Open access
SCShusen Chen
Shusen Chen
JZJiamin Zhu
Jiamin Zhu
FWFeng Wang
Feng Wang
ZGZhifeng Guan
Zhifeng Guan
YGYangyang Ge
Yangyang Ge
JCJing Cai
Jing Cai
LncRNAs and their role in cancer stem cells LncRNAs and their role in cancer stem cells

27 May 2014 in Diagnostic Pathology
Verified
Journal Article
Open access
PDF file
QZQu zhang
Qu zhang
CZChi Zhang
Chi Zhang
XYXi Yang
Xi Yang
BYBaixia Yang
Baixia Yang
JWJinfeng Wang
Jinfeng Wang
JMJianxin Ma
Jianxin Ma
The radiation resistance of prostate cancer remains the primary obstacle to improve patient survival. This study aimed to investigate the effects of berberine, a commonly used natural product, on the radiosensitivity of prostate cancer. Prostate cancer cell line LNCaP and DU-145 were subjected to hypoxia and/or ionizing radiation (IR), in the presence or absence of berberine treatment. Cell growth and colony formation, and apoptosis were evaluated. Moreover, LNCaP cells were xenografted into nude mice and subjected to IR and/or berberine treatment. The expression of HIF-1α and VEGF in prostate cancer cells and xenografts was detected by Western blot analysis. Berberine increased radiosensitivity of prostate cancer cells and xenografts in a dose dependent manner, and this was correlated with the inhibition of HIF-1α and VEGF expression. Berberine may inhibit the expression of HIF-1α and VEGF and thus confer radiosensitivity on prostatic cancer cells. Berberine has potential application as an adjuvant in radiotherapy of prostatic cancer. The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1519827543125021 .

16 April 2016 in SpringerPlus
Verified
Journal Article
Open access
PDF file
CTCheng Tan
Cheng Tan
XQXia Qian
Xia Qian
ZGZhifeng Guan
Zhifeng Guan
BYBaixia Yang
Baixia Yang
YGYangyang Ge
Yangyang Ge
JCJing Cai
Jing Cai
Esophageal cancer, which consist of esophageal adenocarcinoma and esophageal squamous cell carcinoma, is one of the most common malignant tumors in the world, especially in the south of Iran and China. To find and investigate the biomarkers in the initiation, development and progression of esophageal cancer will help us predict the prognosis of esophageal cancer patients and improve the curative effect and survival rate. Here, we reviewed the potential biomarkers of esophageal cancer in three aspects: Immunohistochemical markers, blood-based markers, miRNA markers and Gene expression profiling. All these biomarkers provided promising therapeutic targets for the diagnosis, treatment, and prognosis of esophageal cancer.

12 November 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
XXXiaochun Xia
Xiaochun Xia
BYBaixia Yang
Baixia Yang
XZXiaogang Zhai
Xiaogang Zhai
XLXiangyang Liu
Xiangyang Liu
KSKang Shen
Kang Shen
JCJing Cai
Jing Cai
To date, many studies have shown that microRNAs (miRNA) exhibit altered expression in various cancers and may play an important role as prognostic biomarker of cancers. The present meta-analysis summarizes the recent advances in the use of microRNA-21 (miR-21) in the assessment of colorectal cancer and analyzes the prognostic role of miR-21 for survival outcome. The present meta-analysis was performed by searching PubMed through multiple search strategies. Data were extracted from studies comparing overall survival (OS) in patients with colorectal cancer who showed higher expression of miR-21 than similar patients. Pooled hazard ratios (HRs) of miR-21 for survival and 95% confidence intervals (CI) were calculated. Seven studies with a total of 1174 patients were included this meta-analysis. For overall survival (OS), the pooled hazard ratio (HR) of higher miR-21 expression in colorectal cancer was 1.76 (95% CI: 1.34–2.32, P=0.000). After elimination of heterogeneity, the pooled HR was 2.32 (95% CI: 1.82–2.97, P=0.000), which was found to significantly predict poorer survival. The subgroup analysis suggested that elevated miR-21 level and patients’ survival correlated with III/IV stage (HR=5.35, 95% CI: 3.73–7.66). The present findings suggest that high expression of miR-21 might predict poor prognosis in patients with colorectal cancer.

28 August 2019 in Bioscience Reports
Verified
Journal Article
Open access
JZJiamin Zhu
Jiamin Zhu
SCShusen Chen
Shusen Chen
BYBaixia Yang
Baixia Yang
WMWeidong Mao
Weidong Mao
XYXi Yang
Xi Yang
JCJing Cai
Jing Cai
Radiotherapy is one of the main modalities of cancer treatment. However, tumor recurrence following radiotherapy occurs in many cancer patients. A key to solving this problem is the optimization of radiosensitivity. In recent years, long non-coding RNAs (lncRNAs), which affect the occurrence and development of tumors through a variety of mechanisms, have become a popular research topic. LncRNAs have been found to influence radiosensitivity by regulating various mechanisms, including DNA damage repair, cell cycle arrest, apoptosis, cancer stem cells regulation, epithelial–mesenchymal transition, and autophagy. LncRNAs are expected to become a potential therapeutic target for radiotherapy in the future. This article reviews recent advances in the role and mechanism of lncRNAs in tumor radiosensitivity.

2 September 2016 in Pathology and Oncology Research
Verified
Journal Article
Closed access
PDF file
CTCheng Tan
Cheng Tan
XQXia Qian
Xia Qian
YGYangyang Ge
Yangyang Ge
BYBaixia Yang
Baixia Yang
FWFeng Wang
Feng Wang
JCJing Cai
Jing Cai